outcome should be the result of the specific effects of the treatment. But is this rather simplistic logic really true?
In many areas of medicine, we do not have a credible placebo. By credible, I mean a placebo that is indistinguishable from the real treatment. Imagine a trial of osteopathy (a largely manual treatment) for neck pain where the control group receives oral placebo tablets. This too would be a placebo-controlled trial, but it could never be patient blind. Patients' beliefs and expectations about osteopathy and an oral medication might differ. Because expectations can move mountains, this effect could significantly confound our results to the point of nonrecognition. It follows that placebo control makes little sense without patient blinding.
Much thought and innovation has therefore gone into designing placebos or sham interventions for nonpharmacological treatments. For instance, researchers in the field of acupuncture have gone to great lengths to design sham devices that for the patient, create a perfect illusion of the real thing. More and more rigorously designed studies using such devices are now emerging, and many seem to suggest that they are just as effective as real acupuncture.
The finding by Bausell et al. points in the same direction. For dental pain, acupuncture was not better than sham, but patients' beliefs were a strong determinant of perceived pain. This means, in my view, that it is not enough to design clever credible placebos; we also have to test how successful our blinding is. If it is less than 100%, there is a danger that differences in beliefs and expectations create misleading results.
Most readers of this editorial will by now have reached the conclusion that all of this has nothing to do with them; they are not interested in acupuncture! But wait, how do you know that in drug trials, the experimental pill generates the same beliefs and expectations as the placebo pill? They may look the same, but they could have different (wanted and unwanted) effects, and in most cases, they will! These effects can lead to the deblinding of patients during the course of a drug trial. As a consequence, patients' beliefs might change in a systematic fashion. It follows that even in conventional drug trials, beliefs and expectations created during the treatment period can confound the results. To be on the safe side, my advice is to monitor such factors whenever there is even a suspicion that they could influence the results. A belief can move mountains, but it should not confound the results of our research.
